Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has given notice of its intention to redeem all of the outstanding 3.25% Convertible Senior Subordinated Notes due 2024 (the "Notes").
As of February 25, 2011, $329,229,000 million in aggregate principal amount of the Notes was outstanding. In accordance with the terms of the indenture governing these Notes, they will be redeemed on March 30, 2011 (the "Redemption Date"), at 100% of their principal amount plus accrued and unpaid interest to the Redemption Date.
The Notes are convertible at any time prior to March 29, 2011, at a rate of 24.8756 shares of common stock per $1,000 principal amount of the Notes surrendered. The Notes surrendered for conversion will be settled in cash in accordance with the provisions of the indenture.
The Bank of New York Mellon, the trustee for the 2024 Convertible Notes, is mailing a Notice of Redemption to all registered holders of the Notes today. Copies of such Notice of Redemption and additional information relating to the procedure for redemption and/or conversion of the Notes may be obtained from The Bank of New York Mellon by calling 800-254-2826.
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies